Narcolepsy is not associated with increased risk for mortality of any type, even among patients with a higher prevalence of psychiatric comorbidities, new research shows.

VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and ...

Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need Leverages Existing ...

The DVLA has issued a full list of health conditions that drivers must report to them or risk facing a £1,000 fine ...

When entrepreneur and author Michelle Weger first started falling asleep in her university classrooms at 17, the teenager who ...

A full list of health conditions has been published on the organisation’s website, with motorists being urged to check ...

Here is a list of the most common medical conditions you might need to report to the DVLA and what the law says about them ...

TOKYO, Sept. 8, 2025 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the results from a Phase Ib clinical trial (NCT06462404) of its in-house ...

Alkermes plc (NASDAQ:ALKS) Q2 2025 Earnings Call Transcript July 29, 2025 Alkermes plc beats earnings expectations. Reported EPS is $0.517, expectations were $0.41. Operator: Greetings, and welcome to ...

In late November, Georgia beat Georgia Tech in a heart-stopping, eight-overtime classic. In one of the most exciting games of the entire college football season, Georgia’s fifth-year defensive tackle, ...

– Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With Narcolepsy Type 1 – – Alixorexton ...